Esther Merilien is a Hollywood, Florida based nurse practitioner. Active license number of Esther Merilien is 11012434 in Florida. Her current practice location is 3700 Johnson St, Hollywood. Patients can reach her at 954-265-1400 or can fax her at 954-276-0386. Esther Merilien is APRN and her NPI number (Unique professional ID assigned by NPPES) is 1346817616. Esther Merilien has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Esther Merilien speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1346817616
NPI Enumeration Date:
07 Jun, 2021
NPI Last Update On:
30 Apr, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Esther Merilien are as mentioned below.
License Number
Specialization
State
Status
11012434
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Esther Merilien 2900 Corporate Way, Door D Miramar, Florida
Zip:
33025-3925
Phone Number:
954-276-5685
Fax Number:
954-985-7074
Patients can reach Esther Merilien at 3700 Johnson St, Hollywood, Florida or can call to book an appointment on 954-265-1400.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.